Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 1,500 | $20.66 | $30,991.05 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 28,048 | $20.35 | $570,844.12 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,125 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 20, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 29,548 | $3.00 | $88,644.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 22, 2022 00:52 UTC Amendment |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 900 | $20.62 | $18,555.48 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 22, 2022 00:52 UTC Amendment |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 19,552 | $19.84 | $387,917.55 |
DisclosureSEC source: 0001209191-22-054346 · doc4a.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F3 · balance_after: Includes restricted stock units. F4 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionOptions (Right to buy) · Derivative | 20,452 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,399 Underlying: Common Stock · 20,452 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 900 | $20.62 | $18,555.48 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
SaleCommon Stock | 19,552 | $19.84 | $387,917.55 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:09 UTC |
Shaker BenjaminChief Markets Officer
|
Exercise / conversionCommon Stock | 20,452 | $3.00 | $61,356.00 |
DisclosureSEC source: 0001209191-22-054260 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,289 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $21.79 | $117,577.76 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.62 to $21.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 14, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,685 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| October 14, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $21.79 | $117,576.68 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.55 to $22.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 14, 2022 Filed Oct 19, 2022 00:08 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-054018 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,081 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $24.27 | $196,465.66 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.21 to $24.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 427 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 427 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:56 UTC |
Kasenchak PriscillaChief Accounting Officer
|
GrantOptions (Rights to Buy) · Derivative | 5,413 | $0.00 Strike: $23.87 | $0.00 |
DisclosureSEC source: 0001209191-22-052868 · doc4.xml · derivative · entry 2 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,413 Underlying: Common Stock · 5,413 shares Expires 2032-10-03 F2 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. F2 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:56 UTC |
Kasenchak PriscillaChief Accounting Officer
|
GrantCommon Stock | 3,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052868 · doc4.xml · nonDerivative · entry 1 Kasenchak Priscilla · CIK 0001793048 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,352 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of October 3, 2022, subject to continued employment. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,175 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $23.17 | $187,503.18 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,426 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.92 to $23.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 427 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:57 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-052869 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. F2 · balance_after: The total was decreased by 427 shares as reported in the Form 4 Amendment filed on September 29, 2022. Read SEC document |
| September 27, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 10,792 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,269 Underlying: Common Stock · 10,792 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| September 27, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 10,792 | $22.98 | $247,971.02 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.74 to $23.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 27, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 10,792 | $4.49 | $48,456.08 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,061 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $22.62 | $122,072.09 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.47 to $22.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 20:04 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-051454 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · derivative · entry 7 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,457 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $23.08 | $186,790.90 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · nonDerivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.95 to $23.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 13,490 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,551 Underlying: Common Stock · 13,490 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 2,944 | $23.02 | $67,779.42 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.015 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 10,546 | $22.56 | $237,896.67 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,797 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.015 to $23.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 13,490 | $4.49 | $60,570.10 |
DisclosureSEC source: 0001209191-22-049493 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,041 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $20.90 | $112,775.32 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.65 to $21.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 24, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 5,396 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,437 Underlying: Common Stock · 5,396 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 5,396 | $20.49 | $110,552.71 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.42 to $20.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:10 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 5,396 | $4.49 | $24,228.04 |
DisclosureSEC source: 0001209191-22-047480 · doc4.xml · nonDerivative · entry 1 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 17:31 UTC |
CD&R Investment Associates IX, Ltd.10% owner
CD&R Vector Holdings, L.P.10% owner
|
SaleCommon Stock | 11,337,500 | $24.35 | $276,068,125.00 |
DisclosureSEC source: 0001209191-22-045671 · doc4.xml · nonDerivative · entry 1 CD&R Investment Associates IX, Ltd. · CIK 0001624514 · 10% owner CD&R Vector Holdings, L.P. · CIK 0001852347 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By affiliate Disclosed balance after: 194,611,308 F1 · ownership.direct: Following the transaction reported herein, CD&R Vector Holdings, L.P. ("CD&R Stockholder") directly owns 194,611,308 shares of the Issuer's Common Stock. CD&R Investment Associates IX, Ltd., as the general partner of CD&R Stockholder, may be deemed to beneficially own the shares of Common Stock held by CD&R Stockholder. F2 · ownership.direct: CD&R Investment Associates IX, Ltd. expressly disclaims beneficial ownership of the shares of Common Stock held by CD&R Stockholder, except to the extent of its pecuniary interest therein. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:35 UTC |
Schwaneke Jeffrey A.Director
|
GrantOptions (Rights to Buy) · Derivative | 9,680 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001209191-22-045617 · doc4.xml · derivative · entry 2 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,680 Underlying: Common Stock · 9,680 shares Expires 2032-08-10 F2 · derivative.exercise_date: Options that vest in three equal installments on each anniversary of August 10, 2022, subject to continued service as a director. F2 · derivative.expiration_date: Options that vest in three equal installments on each anniversary of August 10, 2022, subject to continued service as a director. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 20:35 UTC |
Schwaneke Jeffrey A.Director
|
GrantCommon Stock | 4,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-045617 · doc4.xml · nonDerivative · entry 1 Schwaneke Jeffrey A. · CIK 0001446919 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,009 F1 · shares: Restricted stock units that vest in full on August 10, 2023, subject to continued service as a director. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · derivative · entry 6 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,833 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $23.96 | $193,927.38 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · nonDerivative · entry 4 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.81 to $24.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionCommon Stock | 8,094 | $4.49 | $36,342.06 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · nonDerivative · entry 3 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
Exercise / conversionOptions (Rights to Buy) · Derivative | 8,094 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · derivative · entry 5 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,927 Underlying: Common Stock · 8,094 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on January 31, 2020 and vest in four equal installments on January 31st of each of 2021, 2022, 2023, and 2024. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 20:30 UTC |
Kornitzer BenjaminChief Med. & Quality Officer
|
SaleCommon Stock | 8,094 | $26.09 | $211,144.94 |
DisclosureSEC source: 0001209191-22-044802 · doc4.xml · nonDerivative · entry 2 Kornitzer Benjamin · CIK 0001855842 · Chief Med. & Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,853 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.92 to $26.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.